Integer Holdings Corporation has secured stockholder approval for its merger with Armstrong Parent, Inc., a significant step in the company’s growth strategy. The approval was granted during a special meeting held on October 21, 2026, where stockholders voted on proposals related to the merger agreement. This merger is expected to enhance Integer's market position in the electromedical and electrotherapeutic apparatus industry.
Integer Holdings Corp, headquartered in Plano, Texas, operates in the electromedical and electrotherapeutic apparatus sector, identified under SIC code 3845. The company trades on the New York Stock Exchange under the ticker symbol ITGR. Integer has been actively involved in the market, with its recent filings indicating a robust engagement with stockholders and regulatory bodies.
According to the filing, as of September 8, 2026, there were 33,997,068 shares of common stock outstanding, with approximately 76.70% represented at the special meeting. The stockholders voted on three proposals, with the first proposal to adopt the merger agreement receiving overwhelming support. Specifically, 26,065,335 votes were cast in favor, while only 10,513 votes were against, and 1,993 abstained.
The second proposal, which sought to approve the executive compensation related to the merger, also passed, garnering 23,859,897 votes for, against 2,172,522 votes, and 45,422 abstentions. The third proposal regarding the adjournment of the meeting was not necessary, as sufficient votes were already secured.
The filing indicates that the transaction is expected to close by the end of 2026, pending customary closing conditions. This merger, involving affiliates of Kohlberg Kravis Roberts & Co. L.P., reflects a trend of consolidation within the electromedical industry, which may prompt competitors to reassess their strategies in light of Integer's expanded capabilities.
Looking ahead, Integer Holdings Corp will likely continue to engage with stakeholders as the merger progresses. The next steps will involve satisfying any remaining regulatory approvals and completing the necessary financial arrangements to finalize the merger.